Clinical Study
Postcesarean Thromboprophylaxis with Two Different Regimens of Bemiparin
Table 2
Characteristics of the surgery by study group and thrombosis risk factors during the cesarean.
| | Thromboprophylactic | Group A | Group B | | regimen | Bemiparin 3500 IU/5 days | Bemiparin 3500 IU/10 days | | (number of cases) | () | () |
| | Type of cesarean () (%) | | | | Elective | 82 (26.4%) | 88 (26.4%) | | Emergency | 229 (73.6%) | 247 (73.6%) | | Type of anesthesia () (%) | | | | Locoregional | 278 (89.7%) | 290 (86.6%) | | General | 31 (10.3%) | 45 (13.77%) | | Delivery GW (mean ± SD) | | | | Preterm () (%) | 40 (12.9%) | 41 (12.4%) | | Placental abruption () (%) | 7 (2.3%) | 7 (2.1%) | | IUGR () (%) | 24 (7.7%) | 31 (9.3%) |
|
|
IUGR: intrauterine growth retardation, GW: weeks of gestation.
|
